Testing Laboratories - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Testing industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Testing Laboratories - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Testing Laboratories
Corporate Insider Buy Sell Ratio (Insider Count) - Testing Laboratories
Testing Laboratories - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2022-03-01 NEO / NeoGenomics, Inc. 4 Dieter Cynthia J A - Award D 22,805
2022-03-01 NEO / NeoGenomics, Inc. 4 Mallon Mark A - Award D 142,457
2022-03-01 NEO / NeoGenomics, Inc. 4 Wallar Gina M A - Award D 28,506
2022-03-01 NEO / NeoGenomics, Inc. 4 Mallon Mark A - Award D 347,777
2022-01-11 NEO / NeoGenomics, Inc. 4 McKenzie Kathryn B M - Exercise D 9.07 2,100
2022-01-11 NEO / NeoGenomics, Inc. 4 McKenzie Kathryn B M - Exercise D -2,100
2021-12-31 NEO / NeoGenomics, Inc. 5 Wallar Gina M L - Other D 35.28 363
2021-12-31 NEO / NeoGenomics, Inc. 5 Gilbert Halley E L - Other D 31.30 177
2021-12-30 NEO / NeoGenomics, Inc. 4 Dieter Cynthia J A - Award D 7,643
2021-12-30 NEO / NeoGenomics, Inc. 4 CARDOZA GEORGE A - Award D 61,143
2021-12-30 NEO / NeoGenomics, Inc. 4 Morris Clive A - Award D 30,572
2021-12-30 NEO / NeoGenomics, Inc. 4 Gilbert Halley E A - Award D 45,858
2021-12-30 NEO / NeoGenomics, Inc. 4 Brown Douglas Matthew A - Award D 30,572
2021-12-30 NEO / NeoGenomics, Inc. 4 Mallon Mark A - Award D 152,858
2021-12-30 NEO / NeoGenomics, Inc. 4 Wallar Gina M A - Award D 15,286
2021-12-30 NEO / NeoGenomics, Inc. 4 Bonello William A - Award D 21,400
2021-12-30 NEO / NeoGenomics, Inc. 4 McKenzie Kathryn B A - Award D 30,572
2021-12-30 NEO / NeoGenomics, Inc. 4 BALLIET JENNIFER A - Award D 21,400
2021-12-22 NEO / NeoGenomics, Inc. 4 Johnson Kevin C M - Exercise D -3,334
2021-12-22 NEO / NeoGenomics, Inc. 4 McKenzie Kathryn B M - Exercise D -5,000
2021-12-22 NEO / NeoGenomics, Inc. 4 Johnson Kevin C M - Exercise D 7.27 3,334
2021-12-22 NEO / NeoGenomics, Inc. 4 McKenzie Kathryn B M - Exercise D 9.07 5,000
2021-12-21 NEO / NeoGenomics, Inc. 4 McKenzie Kathryn B S - Sale D 35 -1,846
2021-12-06 NEO / NeoGenomics, Inc. 4 Mallon Mark P - Purchase D 30.63 17,000
2021-11-30 NEO / NeoGenomics, Inc. 4 Bonello William M - Exercise D 7.52 25,000
2021-11-30 NEO / NeoGenomics, Inc. 4 Bonello William M - Exercise D -25,000
2021-11-26 NEO / NeoGenomics, Inc. 4 Brown Douglas Matthew S - Sale D 36.85 -33,334
2021-11-24 NEO / NeoGenomics, Inc. 4 Bonello William S - Sale D 37.13 -25,000
2021-11-24 NEO / NeoGenomics, Inc. 4 Brown Douglas Matthew S - Sale D 36.84 -33,333
2021-11-24 NEO / NeoGenomics, Inc. 4 Bonello William M - Exercise D -25,000
2021-11-24 NEO / NeoGenomics, Inc. 4 Bonello William M - Exercise D 8.03 25,000
2021-11-23 NEO / NeoGenomics, Inc. 4 Brown Douglas Matthew S - Sale D 37.19 -33,333
2021-11-10 NEO / NeoGenomics, Inc. 4 Daly David A - Award D 1,945
2021-11-10 NEO / NeoGenomics, Inc. 4 Daly David A - Award D 1,623
2021-11-01 APDN / Applied DNA Sciences, Inc. 4 Ceccoli Joseph D. A - Award D 10,943
2021-11-01 APDN / Applied DNA Sciences, Inc. 4 Ceccoli Joseph D. A - Award D 19,897
2021-11-01 APDN / Applied DNA Sciences, Inc. 4 SHAMASH YACOV A A - Award D 19,897
2021-11-01 APDN / Applied DNA Sciences, Inc. 4 SHAMASH YACOV A A - Award D 11,937
2021-11-01 APDN / Applied DNA Sciences, Inc. 4 Murrah Judith A - Award D 32,203
2021-11-01 APDN / Applied DNA Sciences, Inc. 4 Murrah Judith A - Award D 19,924
2021-11-01 APDN / Applied DNA Sciences, Inc. 4 Bitzer John III A - Award D 11,689
2021-11-01 APDN / Applied DNA Sciences, Inc. 4 Shorrock Clay A - Award D 25,205
2021-11-01 APDN / Applied DNA Sciences, Inc. 4 Ferguson Elizabeth M. A - Award D 9,948
2021-11-01 APDN / Applied DNA Sciences, Inc. 4 CATELL ROBERT B A - Award D 19,897
2021-11-01 APDN / Applied DNA Sciences, Inc. 4 Hayward James A A - Award D 19,924
2021-11-01 APDN / Applied DNA Sciences, Inc. 4 Ferguson Elizabeth M. A - Award D 19,897
2021-11-01 APDN / Applied DNA Sciences, Inc. 4 Anchin Scott L A - Award D 9,948
2021-11-01 APDN / Applied DNA Sciences, Inc. 4 Jantzen Beth A - Award D 25,205
2021-11-01 APDN / Applied DNA Sciences, Inc. 4 Jantzen Beth A - Award D 19,924
2021-11-01 APDN / Applied DNA Sciences, Inc. 4 Hayward James A A - Award D 199,243
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)